Primary |
Crohn's Disease |
27.7% |
Rheumatoid Arthritis |
26.9% |
Colitis Ulcerative |
8.7% |
Premedication |
5.3% |
Product Used For Unknown Indication |
5.2% |
Ankylosing Spondylitis |
4.1% |
Psoriatic Arthropathy |
3.7% |
Drug Use For Unknown Indication |
3.4% |
Psoriasis |
3.3% |
Inflammatory Bowel Disease |
2.0% |
Hypertension |
1.8% |
Prophylaxis |
1.5% |
Pain |
1.3% |
Osteoporosis |
0.9% |
Behcet's Syndrome |
0.8% |
Arthritis |
0.8% |
Depression |
0.7% |
Diabetes Mellitus |
0.6% |
Gastrooesophageal Reflux Disease |
0.6% |
Blood Pressure |
0.5% |
|
Vomiting |
9.0% |
Infusion Related Reaction |
8.1% |
Crohn's Disease |
7.9% |
Tuberculosis |
7.3% |
Lupus-like Syndrome |
5.8% |
Breast Cancer |
5.2% |
Skin Cancer |
5.2% |
Weight Decreased |
5.1% |
Pneumonia |
4.4% |
Pyrexia |
4.3% |
Herpes Zoster |
4.3% |
Death |
4.2% |
Surgery |
4.0% |
Systemic Lupus Erythematosus |
3.9% |
Lymphoma |
3.9% |
Urticaria |
3.9% |
Neoplasm Malignant |
3.7% |
Pulmonary Tuberculosis |
3.5% |
Pneumocystis Jiroveci Pneumonia |
3.2% |
Rash |
3.1% |
|
Secondary |
Rheumatoid Arthritis |
29.3% |
Crohn's Disease |
25.9% |
Colitis Ulcerative |
7.0% |
Premedication |
6.2% |
Prophylaxis |
4.1% |
Ankylosing Spondylitis |
3.6% |
Psoriasis |
3.0% |
Psoriatic Arthropathy |
3.0% |
Behcet's Syndrome |
2.9% |
Product Used For Unknown Indication |
2.5% |
Drug Use For Unknown Indication |
2.3% |
Hypertension |
2.1% |
Osteoporosis |
1.4% |
Pain |
1.3% |
Antibiotic Prophylaxis |
1.2% |
Inflammatory Bowel Disease |
0.9% |
Diabetes Mellitus |
0.8% |
Arthritis |
0.8% |
Gastritis |
0.7% |
Insomnia |
0.7% |
|
Vomiting |
12.3% |
Infusion Related Reaction |
9.2% |
Pulmonary Tuberculosis |
6.7% |
Crohn's Disease |
6.3% |
Urticaria |
5.6% |
Weight Decreased |
5.6% |
Tuberculosis |
5.3% |
Pneumocystis Jiroveci Pneumonia |
5.2% |
Breast Cancer |
5.2% |
Pneumonia |
5.0% |
Pyrexia |
4.6% |
Lupus-like Syndrome |
3.8% |
Herpes Zoster |
3.4% |
Rash |
3.3% |
Tremor |
3.3% |
Tachycardia |
3.3% |
Lymphoma |
3.2% |
Urinary Tract Infection |
3.1% |
Sepsis |
2.8% |
Vision Blurred |
2.6% |
|
Concomitant |
Rheumatoid Arthritis |
27.7% |
Product Used For Unknown Indication |
15.4% |
Crohn's Disease |
13.5% |
Drug Use For Unknown Indication |
8.4% |
Osteoporosis |
6.0% |
Psoriatic Arthropathy |
5.2% |
Psoriasis |
3.5% |
Pain |
3.4% |
Arthritis |
2.5% |
Hypertension |
2.2% |
Depression |
1.9% |
Colitis Ulcerative |
1.7% |
Ankylosing Spondylitis |
1.7% |
Prophylaxis |
1.3% |
Anxiety |
1.1% |
Asthma |
1.0% |
Diarrhoea |
0.9% |
Blood Cholesterol Increased |
0.9% |
Hypothyroidism |
0.9% |
Acne |
0.9% |
|
Weight Decreased |
11.9% |
Drug Ineffective |
11.4% |
Rheumatoid Arthritis |
11.4% |
Psoriasis |
7.1% |
Therapeutic Response Decreased |
5.8% |
Vomiting |
5.0% |
Pain |
4.8% |
Pyrexia |
4.6% |
Urticaria |
4.1% |
Weight Increased |
4.0% |
Wrist Fracture |
3.8% |
Crohn's Disease |
3.6% |
Urinary Tract Infection |
3.5% |
Vasculitis Necrotising |
3.3% |
Nausea |
3.0% |
Therapy Non-responder |
3.0% |
Pain In Extremity |
2.6% |
Dyspnoea |
2.5% |
Tremor |
2.5% |
Myocardial Infarction |
2.3% |
|
Interacting |
Product Used For Unknown Indication |
23.9% |
Rheumatoid Arthritis |
23.9% |
Crohn's Disease |
21.7% |
Juvenile Arthritis |
10.9% |
Depression |
8.7% |
Germ Cell Cancer |
6.5% |
Contraception |
2.2% |
Psoriasis |
2.2% |
|
Infusion Related Reaction |
30.8% |
Immunosuppression |
15.4% |
Respiratory Tract Infection |
15.4% |
Drug Interaction |
7.7% |
Leukopenia |
7.7% |
Renal Cancer |
7.7% |
Stomatitis |
7.7% |
Vasculitis |
7.7% |
|